Table 1.
Respiratory tissue parameters under baseline conditions, during MCh infusion at a dose of 24 μg/kg/min, and their percentage changes in the different groups
| G (cmH2O/l) | Change in G | H (cmH2O/l) | Change in H | |||
|---|---|---|---|---|---|---|
| Baseline | MCh 24 μg/kg/min | % | Baseline | MCh 24 μg/kg/min | % | |
| CC | 866 ± 49 | 1150 ± 76* | 33 ± 5 | 2927 ± 299 | 3767 ± 334* | 31 ± 4 |
| CS | 736 ± 42 | 968 ± 78* | 31 ± 5 | 2936 ± 167 | 3329 ± 195* | 15 ± 6 |
| VIP | 735 ± 33 | 991 ± 49* | 37 ± 10 | 2589 ± 258 | 3139 ± 231* | 24 ± 5 |
| ILO | 802 ± 84 | 930 ± 65* | 21 ± 9 | 2972 ± 397 | 3061 ± 147 | 10 ± 10 |
| SIL | 964 ± 45 | 1159 ± 50* | 21 ± 6 | 3240 ± 281 | 3741 ± 278* | 16 ± 3 |
| TEZ | 727 ± 34 | 911 ± 58* | 25 ± 3 | 2370 ± 156 | 3001 ± 232* | 26 ± 2 |
CC: control group, CS: shunt, no treatments, VIP: shunt, treatment with VIP, ILO: shunt, treatment with iloprost, SIL: shunt, treatment with sildenafil, TEZ: shunt, treatment with tezosentan.
*: p < 0.05 vs. the value obtained under baseline conditions within a group.